Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract

Journal of Infectious Diseases

Volumn 179, Issue 4, 1999, Pages 871-882

  Hart, Clyde E ^a   Lennox, Jeffrey L ^b   Pratt Palmore, Melody ^b   Wright, Thomas C ^b   Schinazi, Raymond F ^b   Evans Strickfaden, Tammy ^b   Bush, Timothy J ^b   Schnell, Cathy ^b   Conley, Lois J ^b   Clancy, Kelly A ^b   Ellerbrock, Tedd V ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; NUCLEOSIDE ANALOG; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE GENITAL SYSTEM; GENITAL TRACT INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX MUCUS; VAGINA SECRETION; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 0032924466     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314656     Document Type: Article

References (34)

1. Mostad SB, Kreiss JK. Shedding of HIV in the genital tract. AIDS 1996; 10:1305-15.
2. Kuhn, L, Abrams, EJ, Matheson PB, et al. Timing of maternal-infant HIV transmission: associations and early polymerase chain reaction results. AIDS 1997;11:429-31.
3. Vogt MW, Witt DJ, Craven DE, Byington R, Crawford DF, Schooley RT. Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS. Lancet 1986;1:525-7.
4. Wofsy CB, Cohen JB, Hauer LB, et al. Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus. Lancet 1986;1:527-9.
5. Vogt MW, Witt DJ, Craven DE, et al. Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndrome. Ann Intern Med 1987;106:380-2.
6. Van de Perre P, DeClerq A, Cogniaux-Leclerc J, Nzaramba D, Butzer JP, Sprecher-Goldberger S. Detection of HIV p17 antigen in lymphocytes but not epithelial cells from cervicovaginal secretions of women seropositive for HIV: implications for heterosexual transmission of the virus. Genitourin Med 1988;64:30-3.
7. Henin Y, Mandelbrot L, Henrion R, Pradinaud R, Coulaud JP, Montagnier L. Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J Acquir Immune Defic Syndr 1993;6: 72-5.
8. Clemetson DBA, Moss, GB, Willerford, DM, et al. Detection of HIV DNA in cervical and vaginal secretions. JAMA 1993;269:2860-4.
9. Kreiss J, Willerford DM, Hensel M, et al. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis 1994;170:1597-601.
10. Zorr B, Schafer APA, Dilger I, Habermehl KO, Kosh M. HIV-1 detection in endocervical swabs and mode of HIV-1 infection. Lancet 1994;343: 852.
11. Nielsen K, Boyer P, Dillon M, et al. Presence of human immunodeficiency virus (HIV) type 1 and HIV-1 specific antibodies in cervicovaginal secretions of infected mothers and in gastric aspirate of their infants. J Infect Dis 1996;173:1001-4.
12. John GC, Nduati RW, Mbori-Ngacha D, et al. Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis 1997;175:57-62.
13. Rasheed S, Zhiliang L, Dong X, Kovacs A. Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus infected women. Am J Obstet Gynecol 1996;175:122-30.
14. Uvin SC, Caliendo AM. Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus seropositive women. Obstet Gynecol 1997;90:739-43.
15. Loussert-Ajaka I, Mandelbrot L, Delmas MC, et al. HIV-1 detection in cervicovaginal secretions during pregnancy. AIDS 1997;11:1575-81.
16. Iversen AKN, Larsen AR, Jensen T, et al. Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions. J Infect Dis 1998;177:1214-20.
17. Goulston C, McFarland W, Katzenstein D. Human immunodeficiency viruses type 1 RNA in the female genital tract. J Infect Dis 1998;177:1100-3.
18. Davies A. A preliminary investigation using p-nitrophenyl phosphate to quantitate acid phosphatase on swabs examined in cases of sexual assault. Med Sci Law 1978;18:174-8.
19. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Swok S, et al. A rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol 1994;32:292-300.
20. Piatak M, Luk KC, Williams B, Lifson JD. Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. BioTechniques 1993;14:70-80.
21. Guenthner PC, Hart CE. A quantitative competitive PCR assay for HIV-1 using a microtiter-based detection system. BioTechniques 1998;24:810-6.
22. Cassol S, Salas T, Lapointe N, Arella M, Rudnik J, O'Shaughnessy M. Improved detection of HIV-1 envelope sequences using optimized PCR and inosine substituted primers. Mol Cell Probes 1991;5:157-60.
23. Myers G, Korber B, Berzofsky JA, Smith RF, Pavlakis GN, eds. A compilation of analysis of nucleic acid and amino acid sequences. In: Human retroviruses and AIDS. Los Alamos, NM: Los Alamos National Laboratory, 1991.
24. Sassa S. Regulation of the genes for heme pathway enzymes in erythroid and in non-erythroid cell. Int J Cell Cloning 1990;8:10-26.
25. Saltarelli MJ, Hadziyannis E, Hart CE, et al. Analysis of human immunodeficiency virus type 1 mRNA splicing patterns during disease progression in peripheral blood mononuclear cells from infected individuals. AIDS Res Hum Retroviruses 1996;12:1443-56.
26. Vandamme AM, Schmit JC, Van Dooren S, et al. Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the Amplicor HIV Monitor test. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:127-39.
27. Weverling GJ, Lange JM, de Jong MD, de Weerd H, Goudsmit J, de Wolf F. A comparison of serum HIV-1 RNA levels as measured by two quantitative assays in zidovudine-treated, asymptomatic, HIV-infected individuals. Antiviral Ther 1996;1:255-63.
28. Gupta P, Mellors J, Kingsley L, et al. High viral load in semen of human immunodeficiency virus type 1 infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors. J Virol 1997;71:6271-5.
29. Vernazza P, Gilliam BL, Dyer J, et al. Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS 1997;11: 987-93.
30. Vernazza PL, Gilliam BL, Flepp M, et al. Effect of antiviral treatment on the shedding of HIV-1 in semen. AIDS 1997;11:1249-54.
31. Ghys PD, Fransen K, Diallo MO, et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire. AIDS 1997;11: F85-93.
32. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1996;335:1621-9.
33. Fang G, Burger H, Grimson R, et al. Maternal plasma immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission. Proc Nat Acad Sci USA 1995;92:12100-4.
34. Dickover RE, Garatty EM, Herman SA, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission: effect of maternal zidovudine treatment on viral load. JAMA 1996;275:599-605.